Vitamin B12 / homoC Cancer Research Results

VitB12, Vitamin B12: Click to Expand ⟱
Features:

Vitamin B12 = cobalamin (water-soluble vitamin; forms: methylcobalamin, adenosylcobalamin, cyanocobalamin, hydroxocobalamin). Sources: animal-derived foods; requires intrinsic factor–mediated absorption; transport via transcobalamin (TCII). Primary mechanisms (ranked):
1) Methionine synthase cofactor → homocysteine → methionine → SAM → DNA/RNA/histone methylation (one-carbon metabolism integration).
2) Methylmalonyl-CoA mutase cofactor → odd-chain FA / branched-chain AA metabolism; mitochondrial anaplerosis support.
3) Genome stability support (via nucleotide synthesis + methylation balance).
Bioavailability/PK relevance: Active absorption saturable (~1–2 µg/meal via IF); passive diffusion at high oral doses (~1%); serum levels tightly regulated; intracellular utilization depends on TCII uptake and lysosomal processing.
In-vitro vs oral exposure: Most cancer cell studies use supraphysiologic cobalamin or manipulate one-carbon flux; effects typically reflect methylation / nucleotide synthesis dependency rather than direct cytotoxicity.
Clinical evidence status: Essential nutrient; deficiency correction clearly beneficial; no established anticancer efficacy; epidemiology mixed (very high serum B12 sometimes correlates with cancer presence—likely reverse causality/biomarker phenomenon rather than causation).

Helps make red blood cells, metabolize food and prevent nerve damage.

Vitamin B12 (Cobalamin) — Cancer vs Normal Pathway Effects

Rank Pathway / Axis Cancer Cells (↑ / ↓ / ↔) Normal Cells (↑ / ↓ / ↔) TSF Primary Effect Notes / Interpretation
1 One-carbon metabolism (Methionine synthase → SAM) ↑ methylation capacity; ↑ nucleotide synthesis (proliferation support) ↑ genome stability; ↑ normal DNA synthesis R→G Methyl donor cycling Supports SAM production; in rapidly dividing tumors may facilitate growth if not limiting.
2 DNA methylation / Epigenetics ↔ / ↑ (context-dependent; can restore normal methylation if deficient) ↑ methylation homeostasis G Epigenetic stability Deficiency → hypomethylation/genomic instability; supplementation restores baseline rather than inducing supraphysiologic hypermethylation in most settings.
3 Nucleotide synthesis (via folate cycle coupling) ↑ proliferation support (if B12 limiting) ↑ normal hematopoiesis R→G DNA replication capacity Mechanistically linked to folate; deficiency leads to megaloblastic anemia.
4 Mitochondrial metabolism (Methylmalonyl-CoA mutase) ↔ (supports baseline metabolism) ↑ mitochondrial function R Anaplerotic support Prevents methylmalonic acid accumulation; preserves mitochondrial efficiency.
5 ROS ↔ (indirect) ↓ oxidative stress (deficiency correction) R Redox balance (secondary) Effects mediated through improved mitochondrial and methylation balance.
6 NRF2 ↔ (no direct axis) ↔ G Adaptive response (indirect) No primary NRF2-targeting activity established.
7 Ca2+ ↔ ↔ P Not a core pathway No meaningful Ca²⁺ modulation axis.
8 HIF-1α / Warburg ↔ (indirect via proliferation capacity) ↔ G Metabolic permissiveness No direct hypoxia pathway targeting; effects are permissive rather than suppressive.
9 Ferroptosis ↔ ↔ R Not established No defined ferroptotic mechanism.
10 Clinical Translation Constraint Essential nutrient; correction of deficiency critical. No validated anticancer benefit; very high serum B12 often reflects disease state rather than supplementation causality. — Evidence Interpret epidemiologic associations cautiously (reverse causation common).

TSF legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr
homoC, homocysteine: Click to Expand ⟱
Source:
Type:
Homocysteine is a sulfur-containing amino acid produced during the metabolism of methionine. Elevated homocysteine levels and alterations in its metabolic enzymes have been associated with various pathological processes, including oxidative stress, DNA damage, and inflammation.
-Elevated plasma homocysteine levels (hyperhomocysteinemia) are a well‐established risk factor for cardiovascular diseases.
-Some studies have suggested that high levels of homocysteine might be associated with an increased risk of certain cancers.
-Vitamins like folate, B6, and B12 are key regulators of homocysteine metabolism, some research has examined whether supplementation might modulate cancer risk. However, clinical outcomes have been mixed and further research is needed.

-Various clinical trials have shown that the oral supplementation of folic acid, B6, and B12 vitamins significantly lowers circulating homocysteine levels.
Scientific Papers found: Click to Expand⟱
2174- FA,  VitB12,   
- Analysis, Var, NA
homoC↓, eff↑, eff↑, eff↑, eff↝, homoC↝, other?,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Core Metabolism/Glycolysis ⓘ

homoC↓, 1,   homoC↝, 1,  

Transcription & Epigenetics ⓘ

other?, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 3,   eff↝, 1,  
Total Targets: 5

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: homoC, homocysteine
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:165  Target#:1257  State#:%  Dir#:4
  wNotes=0  sortOrder:rid,rpid

 

Home Page